The Zhitong Finance App learned that the Shanghai Stock Exchange issued a notice after the market on September 4. According to the relevant provisions of the “Shanghai Stock Exchange Shanghai-Hong Kong Stock Exchange Business Implementation Measures”, Yingpai Pharmaceutical (07630.HK) was officially transferred to the Hong Kong Stock Exchange's securities list. The adjustment will take effect on September 7 (Monday). This means that mainland investors can now directly trade Yingpai Pharmaceutical through the Shanghai-Shenzhen-Hong Kong Stock Connect, officially unlocking southbound capital.
Zhitongcaijing · 1d ago
Share
Listen to the news
The Zhitong Finance App learned that the Shanghai Stock Exchange issued a notice after the market on September 4. According to the relevant provisions of the “Shanghai Stock Exchange Shanghai-Hong Kong Stock Exchange Business Implementation Measures”, Yingpai Pharmaceutical (07630.HK) was officially transferred to the Hong Kong Stock Exchange's securities list. The adjustment will take effect on September 7 (Monday). This means that mainland investors can now directly trade Yingpai Pharmaceutical through the Shanghai-Shenzhen-Hong Kong Stock Connect, officially unlocking southbound capital.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending